Statement Of Income

Fuji Pharma Co.,Ltd. - Filing #7357403

Concept 2023-10-01 to
2023-12-31
2022-10-01 to
2022-12-31
Statement of income
Statement of income
Net sales
10,746,000,000 JPY
9,996,000,000 JPY
Net sales
Operating revenue
Cost of sales
Cost of sales
7,193,000,000 JPY
5,962,000,000 JPY
Operating expenses
Selling, general and administrative expenses
3,692,000,000 JPY
2,843,000,000 JPY
Operating profit (loss)
-140,000,000 JPY
1,190,000,000 JPY
Ordinary profit (loss)
-96,000,000 JPY
1,579,000,000 JPY
Gross profit (loss)
3,552,000,000 JPY
4,034,000,000 JPY
Non-operating income
Interest income
1,000,000 JPY
0 JPY
Gross profit
Selling, general and administrative expenses
Non-operating income
Non-operating income
93,000,000 JPY
434,000,000 JPY
Financial revenue
Other
7,000,000 JPY
13,000,000 JPY
Non-operating expenses
Interest expenses
40,000,000 JPY
24,000,000 JPY
Non-operating expenses
Extraordinary income
3,953,000,000 JPY
JPY
Non-operating expenses
Non-operating expenses
49,000,000 JPY
45,000,000 JPY
Financial expenses
Bond issuance costs
JPY
14,000,000 JPY
Other
8,000,000 JPY
6,000,000 JPY
Extraordinary income
Gain on sale of investment securities
3,118,000,000 JPY
JPY
Profit (loss) before income taxes
3,856,000,000 JPY
1,579,000,000 JPY
Income taxes - current
1,272,000,000 JPY
159,000,000 JPY
Income taxes - deferred
-156,000,000 JPY
305,000,000 JPY
Income taxes
1,116,000,000 JPY
464,000,000 JPY
Profit (loss)
2,739,000,000 JPY
1,114,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.